Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia Academic Article uri icon

Overview

MeSH Major

  • Cladribine
  • Leukemia, Lymphocytic, Chronic, B-Cell

abstract

  • 2-CdA has activity in patients with relapsed or refractory CLL. However, patients who have received multiple prior regimens that included fludarabine are less likely to respond, and there can be significant morbidity. Treatment of patients with less prior therapy earlier in the natural history of the disease may lead to improved and more durable responses.

publication date

  • April 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7707127

Additional Document Info

start page

  • 983

end page

  • 8

volume

  • 13

number

  • 4